It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.



zarxio helps you fight infection

ZARXIO is a man-made form of granulocyte colony-stimulating factor (G-CSF) called filgrastim. G-CSF is a natural substance produced by the body. The purpose of G-CSF is to stimulate the growth of neutrophils, a type of white blood cell that is important in the body’s fight against infection.

saving icon

Enroll in $0 co-pay

Eligible*, commercially insured patients can enroll by phone or online.

administer icon

How is ZARXIO administered?

ZARXIO may be administered by you, a caregiver, or a healthcare professional.

Enroll in $0 co-pay*
faq icon

Frequently Asked Questions

Find answers to frequently asked questions about biosimilars and ZARXIO.

Reference: ZARXIO Prescribing Information. Sandoz Inc. September 2022.

*Eligibility Requirements: Prescription must be for an approved indication. This program is not health insurance. This program is for insured patients only; cash-paying or uninsured patients are not eligible. Patients are not eligible if prescription for ZARXIO is paid, in whole or in part, by any state or federally funded programs, including but not limited to Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, or TRICARE, or private indemnity plans that do not cover prescription drugs, or HMO insurance plans that reimburse the patient for the entire cost of their prescription drugs, or where prohibited by law. Co-Pay Program may apply to out-of-pocket expenses that occurred within 120 days prior to the date of the enrollment. Co-Pay Program may not be combined with any other rebate, coupon, or offer. Co-Pay Program has no cash value. Sandoz reserves the right to rescind, revoke, or amend this offer without further notice.